Exchange: NASDAQ·Updated 07:37 PM EDT
MGX logo

MGX Metagenomi Inc.

$1.00
$0.0068
(0.69%)
Today
Closed $1.00
$0.00
(0.00%)
After Hours
Reported EarningsAug 10
Mkt Cap$37.52M
Vol147,177.00

About MGX

Metagenomi Therapeutics, Inc. is a precision genetic medicines company, which engages in the business of developing next generation gene-editing technologies and therapies. Its business activities include developing gene edit­ing toolbox, ther­a­peu­tic focus, and processing discovery platform. The company was founded by Brian C. Thomas on September 16, 2016 and is headquartered in Emeryville, CA.
52

Neutral Sentiment

How do you feel about MGX?

Trending__Now
$MGX Swing play in at $1.17 IND EOY potential. Cash until 2027 and low current float. Why not?
2

Advertisement|Remove ads.